Financials
Income statement
| Fiscal date | Mar 2025 | Mar 2024 |
|---|---|---|
| Total reported revenue | 32.1B | 27.5B |
| Cost of revenue | 18.5B | 16.0B |
| Gross profit | 13.6B | 11.5B |
| Operating expense | ||
| Research & development | — | — |
| Selling general and admin | — | — |
| Other operating expenses | 8.1B | 7.1B |
| Operating income | 4.7B | 3.8B |
| Non operating interest income | ||
| Income | — | — |
| Expense | 224M | 103M |
| Other income expense | — | — |
| Pretax income | 4.4B | 3.6B |
| Tax provision | 1.1B | 788M |
| Net income | 3.3B | 2.8B |
| Basic EPS | 5.4 | 4.6 |
| Diluted EPS | 5.3 | 4.6 |
| Basic average shares | 608.2M | 606.5M |
| Diluted average shares | 618.5M | 607.8M |
| EBITDA | 5.5B | 4.5B |
| Net income from continuing op. | 4.4B | 3.6B |
| Minority interests | 1M | 6M |
| Preferred stock dividends | 0 | 0 |